Edition:
United States

Trillium Therapeutics Inc (TRIL.OQ)

TRIL.OQ on NASDAQ Stock Exchange Capital Market

7.55USD
15 Dec 2017
Change (% chg)

$-0.20 (-2.58%)
Prev Close
$7.75
Open
$7.90
Day's High
$8.00
Day's Low
$7.55
Volume
15,004
Avg. Vol
20,656
52-wk High
$13.30
52-wk Low
$4.10

Select another date:

Fri, Dec 15 2017

BRIEF-Trillium Therapeutics Inc Files For Mixed Shelf Of Upto $150 Mln

* TRILLIUM THERAPEUTICS INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING Source text : http://bit.ly/2jZxGi0 Further company coverage:

BRIEF-Matrix Capital Management Co Reports A 16.5 Pct Passive Stake In Trillium Therapeutics

* MATRIX CAPITAL MANAGEMENT COMPANY LP REPORTS A 16.5 PCT PASSIVE STAKE IN TRILLIUM THERAPEUTICS INC AS OF NOV 30 - SEC FILING Source text: (http://bit.ly/2yOHuTW) Further company coverage:

BRIEF-Trillium announces private placement to fund development of cancer drugs

* Trillium Therapeutics - ‍entered into subscription agreements for sale of 1.95 million shares & 400,000 Series II non-voting convertible first preferred shares​

BRIEF-Trillium Therapeutics reports Q3 results

* Trillium Therapeutics reports third quarter 2017 financial and operating results

BRIEF-Trillium provides update on small molecule programs

* Trillium says concluded that TTI-2341 appears to be a viable and competitive drug candidate for treatment of brain cancers and brain metastases

Select another date: